Document:

Exhibit 10.2

 

AMENDMENT NO.2 TO SECURED CONVERTIBLE PROMISSORY NOTE

 

This Amendment
No. 2 to the Secured Convertible Promissory Note (the “Amendment”), is made as of June 17, 2022 by VIA Motors International,
Inc., (the “Borrower”). Capitalized terms used but not defined herein shall have the respective meanings given to them
in the Note (defined below).

 

WHEREAS, the
Borrower issued a certain Secured Convertible Promissory Note dated August 30, 2021, as amended on May 20, 2022 (“Note”)
to Ideanomics Inc., (“Lender”) promising to repay the loan amount of $44,800,000.00 advanced by the Lender.

 

WHEREAS, the
Borrower wishes to borrow, and the Lender wishes to advance, an additional amount of US$ 3,200,000.00 on the terms and conditions set
forth in the Note.

 

WHEREAS, the Borrower desires to amend the Note
as provided herein.

 

NOW,
THEREFORE, in consideration of the mutual covenants herein contained and other good and valuable consideration, the mutual receipt
and legal sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, mutually agree as follows:

 

		1.	Notwithstanding anything to the contrary in the Note, effective
as of the date hereof:

 

		·	the principal sum payable under the Note shall be FORTY-EIGHT
MILLION EIGHTEEN THOUSAND ONE HUNDRED ELEVEN Dollars (US$48,018,111).

 

		a.	Simple interest on (i) US$42,500,000 shall accrue from August
30, 2021; (ii) US$ 2,318,111 shall accrue from May 20, 2022, and (iii) US$ 3,200,000 shall accrue from the date hereof, in each case,
till the Maturity Date at the rate of four percent (4%) per annum (such principal and interest together and all other amounts due and
owing under the Note, the “Obligations”).

 

		2.	Except to the extent herein expressly modified by the foregoing
provisions of this Amendment, the Note is hereby ratified and confirmed in all respects.

 

		3.	This Amendment may be executed by electronic signatures and
in any number of counterparts with the same effect as if all signatory parties had signed the same document. All counterparts shall be
construed together and shall constitute one and the same instrument.

 

[signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF, each of the parties hereto has caused
this Amendment to be duly executed and delivered in its name and on its behalf, all as of the day and year first above written.

 

	 	VIA MOTORS INTERNATIONAL, INC., a Delaware corporation
	 	 
	 	By:	/s/ Robert C. Purcell            
	 	Name: Robert C. Purcell
	 	Title: CEO

 

	Acknowledged by:	 
	 	 
	IDEANOMICS, INC., a Nevada corporation	 
	 	 
	By:	/s/ Alf Poor        	 
	Name: Alf Poor	 
	Title: Authorized Signatory	 

 

[Signature Page to Amendment No. 2 to the Convertible Note]Exhibit 10.3

 

AMENDMENT NO.3 TO SECURED CONVERTIBLE PROMISSORY NOTE

 

This Amendment No.
3 to the Secured Convertible Promissory Note (the “Amendment”), is made as of July 12, 2022 by VIA Motors International,
Inc., (the “Borrower”). Capitalized terms used but not defined herein shall have the respective meanings given to them
in the Note (defined below).

 

WHEREAS, the Borrower
issued a certain Secured Convertible Promissory Note dated August 30, 2021, as amended on May 20, 2022 and June 17, 2022 (“Note”)
to Ideanomics Inc., (“Lender”) promising to repay the loan amount of $48,000,000.00 advanced by the Lender.

 

WHEREAS, the Borrower
wishes to borrow, and the Lender wishes to advance, an additional amount of US$ 5,800,000.00 on the terms and conditions set forth in
the Note.

 

WHEREAS, the Borrower desires to amend the Note as provided
herein.

 

NOW, THEREFORE, in
consideration of the mutual covenants herein contained and other good and valuable consideration, the mutual receipt and legal sufficiency
of which are hereby acknowledged, the Parties, intending to be legally bound, mutually agree as follows:

 

	1.	Notwithstanding anything to the contrary in the Note, effective as of the date hereof:

 

		a.	the principal sum payable under the Note shall be FIFTY-THREE MILLION EIGHT HUNDRED THOUSAND Dollars (US$53,800,000.00).
	 	 	 
		b.	Simple interest on (i) US$42,500,000 shall accrue from August 30, 2021; (ii) US$ 2,300,000 shall accrue
from May 20, 2022, (iii) US$ 3,200,000 shall accrue from June 17, 2022, and (iv) US$ 5,800,000 shall accrue from the date hereof, in each
case, till the Maturity Date at the rate of four percent (4%) per annum (such principal and interest together and all other amounts due
and owing under the Note, the “Obligations”).

 

	2.	Except to the extent herein expressly modified by the foregoing provisions of this
Amendment, the Note is hereby ratified and confirmed in all respects.
	 	 
	3.	This Amendment may be executed by electronic signatures and in any number of counterparts with the
                                same effect as if all signatory parties had signed the same document. All counterparts shall be construed together and shall
                                constitute one and the same instrument.

 

[signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF, each of the parties hereto has caused
this Amendment to be duly executed and delivered in its name and on its behalf, all as of the day and year first above written.

 

	 	VIA MOTORS INTERNATIONAL, INC., a Delaware corporation
	 	 
	 	By:	/s/ Robert C. Purcell            
	 	Name: Robert C. Purcell
	 	Title: CEO

 

	Acknowledged by:	 
	 	 
	IDEANOMICS, INC., a Nevada corporation	 
	 	 
	By:	/s/ Alf Poor        	 
	Name: Alf Poor	 
	Title: Authorized Signatory	 

 

[Signature Page to Amendment No. 3 to the Convertible Note]EX-10.22

 Exhibit 10.22 

STANDBY EQUITY PURCHASE AGREEMENT 

THIS STANDBY EQUITY PURCHASE AGREEMENT (this “Agreement”) dated as of July 18, 2022 is made by and between YA
II PN, LTD., a Cayman Islands exempt limited partnership (the “Investor”), and GROVE COLLABORATIVE HOLDINGS, INC., a public benefit company incorporated under the laws of the State of Delaware (the
“Company”). 
 WHEREAS, the parties desire that, upon the terms and subject to the conditions contained herein, the
Company shall have the right to issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $100 million of the Company’s shares of Class A common stock, par value
$0.0001 per share (the “Common Shares”); and 
 WHEREAS, the Common Shares are listed for trading on the New York
Stock Exchange under the symbol “GROV;” and 
 WHEREAS, the offer and sale of the Common Shares issuable hereunder will be
made in reliance upon Section 4(a)(2) under the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the “Securities Act”), or upon such other exemption from the registration requirements of
the Securities Act as may be available with respect to any or all of the transactions to be made hereunder. 
 NOW, THEREFORE,
the parties hereto agree as follows: 
 Article I. Certain Definitions 

“Additional Shares” shall have the meaning set forth in Section 2.01(d)(ii). 

“Adjusted Advance Amount” shall have the meaning set forth in Section 2.01(d)(i). 

“Advance” shall mean any issuance and sale of Advance Shares from the Company to the Investor pursuant to Article II hereof.

 “Advance Date” shall mean the 1st Trading Day after expiration of
the applicable Pricing Period for each Advance. 
 “Advance Notice” shall mean a written notice in the form of Exhibit A
attached hereto to the Investor executed by an officer of the Company and setting forth the number of Advance Shares that the Company desires to issue and sell to the Investor. 

“Advance Notice Date” shall mean each date the Company is deemed to have delivered (in accordance with Section 2.01(b)
of this Agreement) an Advance Notice to the Investor, subject to the terms of this Agreement. 

 “Advance Shares” shall mean the Common Shares that the Company shall issue
and sell to the Investor pursuant to Article II hereof. 
 “Affiliate” shall have the meaning set forth in
Section 3.07. 
 “Agreement” shall have the meaning set forth in the preamble of this Agreement. 

“Applicable Laws” shall mean all applicable laws, statutes, rules, regulations, orders, executive orders, directives,
policies, guidelines and codes having the force of law, whether local, national, or international, as amended from time to time, including without limitation (i) all applicable laws that relate to money laundering, terrorist financing,
financial record keeping and reporting, (ii) all applicable laws that relate to anti-bribery, anti-corruption, books and records and internal controls, including the United States Foreign Corrupt Practices Act of 1977, and (iii) any
Sanctions laws. 
 “Black Out Period” shall have the meaning set forth in Section 6.02 

“Class B Common Stock” means the Company’s Class B common stock, par value $0.0001 per share.

 “Closing” shall have the meaning set forth in Section 2.02. 

“Commitment Amount” shall mean $100,000,000 of Advance Shares, provided that, the Company shall not affect any sales
under this Agreement and the Investor shall not have the obligation to purchase the Common Shares under this Agreement to the extent (but only to the extent) that after giving effect to such purchase and sale the aggregate number of Common Shares
issued under this Agreement would exceed 19.99% of the voting power or number of shares of issued and outstanding Common Shares and Class B Common Stock as of the date of this Agreement, in each case calculated in accordance with the applicable
rules of the Principal Market (the “Exchange Cap”) provided further that, the Exchange Cap will not apply if (a) the Company’s stockholders have approved issuances in excess of the Exchange Cap in accordance with
the rules of the Principal Market or (b) all applicable sales of Shares hereunder equal or exceed the Minimum Price (as defined in Section 312.04 of the NYSE Listed Company Manual) or (c) as to any Advance, the issuance of Advance
Shares in respect of such Advance would be excluded from the Exchange Cap under the rules of the Principal Market (or interpretive guidance provided by the Principal Market with respect thereto) in effect as of the date of determination of whether
this clause (c) applies. For avoidance of doubt, the Company may, but shall be under no obligation to, request its stockholders to approve the issuance of Shares as contemplated by this Agreement; provided that, if stockholder approval
is not obtained in accordance with this Agreement, the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at all times during the term of this Agreement. 

“Commitment Period” shall mean the period commencing on the date hereof and expiring upon the date of termination of this
Agreement in accordance with Section 10.01. 
 “Common Shares” shall have the meaning set forth in the recitals of
this Agreement. 

  
 - 2 - 

 “Company” shall have the meaning set forth in the preamble of this
Agreement. 
 “Company Indemnitees” shall have the meaning set forth in Section 5.02. 

“Condition Satisfaction Date” shall have the meaning set forth in Section 7.01. 

“Environmental Laws” shall have the meaning set forth in Section 4.13. 

“Exchange Act” shall mean the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder. 
 “Exchange Cap” shall have the meaning set forth in the definition of “Commitment Amount”. 

“Excluded Day” shall have the meaning set forth in Section 2.01(d)(i). 

“Hazardous Materials” shall have the meaning set forth in Section 4.13. 

“Indemnified Liabilities” shall have the meaning set forth in Section 5.01. 

“Investor” shall have the meaning set forth in the preamble of this Agreement. 

“Investor Indemnitees” shall have the meaning set forth in Section 5.01. 

“Market Price” shall mean the average of the VWAP of the Common Shares during each Trading Day of the relevant Pricing
Period, other than the VWAP on any Excluded Days. 
 “Material Adverse Effect” shall mean any event, occurrence or
condition that has had or would reasonably be expected to have (i) a material adverse effect on the legality, validity or enforceability of this Agreement or the transactions contemplated herein, (ii) a material adverse effect on the
results of operations, assets, business or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under this Agreement. 
 “Material Outside Event” shall have the meaning set forth in
Section 6.08. 
 “Maximum Advance Amount” in respect of each Advance Notice means a number of Common Shares with a
value equal to $25,000,000, unless otherwise agreed by the parties. 
 “Minimum Acceptable Price” or “MAP”
shall mean the minimum price notified by the Company to the Investor in each Advance Notice, if applicable. 
 “OFAC” shall
have the meaning set forth in Section 4.29. 
 “Ownership Limitation” shall have the meaning set forth in
Section 2.01(c)(i). 

  
 - 3 - 

 “Person” shall mean an individual, a corporation, a partnership, a limited
liability company, a trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof. 

“Plan of Distribution” shall mean the section of a Registration Statement disclosing the plan of distribution of the Shares.

 “Pricing Period” shall mean the three (3) consecutive Trading Days commencing on the Advance Notice Date. 

“Principal Market” shall mean the New York Stock Exchange; provided however, that in the event the Company’s Common
Shares are ever listed or traded on the Nasdaq Global Market, the Nasdaq Capital Market, or the NYSE American, then the “Principal Market” shall mean such other market or exchange on which the Company’s Common Shares are then listed
or traded to the extent such other market or exchange is the principal trading market or exchange for the Common Shares. 

“Prospectus” shall mean any prospectus (including, without limitation, all amendments and supplements thereto) used by the
Company in connection with a Registration Statement. 
 “Prospectus Supplement” shall mean any prospectus supplement to a
Prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act, including, without limitation, any prospectus supplement to be filed in accordance with Section 6.01 hereof. 

“Purchase Price” shall mean the price per Advance Share obtained by multiplying the Market Price by 97.55%. 

“Registrable Securities” shall mean (i) the Shares, and (ii) any securities issued or issuable with respect to any
of the foregoing by way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise. 

“Registration Limitation” shall have the meaning set forth in Section 2.01(c)(ii). 

“Registration Statement” shall mean a registration statement on Form S-1 or Form S-3 or on such other form promulgated by the SEC for which the Company then qualifies and which counsel for the Company shall deem appropriate, and which form shall be available for the registration of the resale by
the Investor of the Registrable Securities under the Securities Act, which registration statement provides for the resale from time to time of the Shares as provided herein. 

“Regulation D” shall mean the provisions of Regulation D promulgated under the Securities Act. 

“Sanctions” shall have the meaning set forth in Section 4.29. 

“Sanctioned Countries” shall have the meaning set forth in Section 4.29. 

  
 - 4 - 

 “SEC” shall mean the U.S. Securities and Exchange Commission. 

“SEC Documents” shall have the meaning set forth in Section 4.05. 

“Securities Act” shall have the meaning set forth in the recitals of this Agreement. 

“Settlement Document” shall have the meaning set forth in Section 2.02(a). 

“Shares” shall mean the Common Shares to be issued from time to time hereunder pursuant to an Advance. 

“Subsidiaries” shall mean any Person in which the Company, directly or indirectly, (x) owns a majority of the
outstanding capital stock or holds a majority of the equity or similar interest of such Person or (y) controls or operates all or substantially all of the business, operations or administration of such Person, and the foregoing are collectively
referred to herein as “Subsidiaries.” 
 “Trading Day” shall mean any day during which the Principal
Market shall be open for business. 
 “Transaction Documents” shall have the meaning set forth in Section 4.02. 

“VWAP” shall mean for any Trading Day, the daily volume weighted average price of the Common Shares for such Trading Day on
the Principal Market during regular trading hours as reported by Bloomberg L.P. 
 Article II. Advances 

Section 2.01 Advances; Mechanics. Upon the terms and subject to the conditions of this Agreement, during the Commitment Period, the Company, at
its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the Investor shall purchase from the Company, Advance Shares by the delivery to the Investor of Advance Notices on the following terms: 

 

	 	(a)	 Advance Notice. At any time during the Commitment Period the Company may require the Investor to
purchase Shares by delivering an Advance Notice to the Investor, subject to the satisfaction or waiver by the Investor of the conditions set forth in Section 7.01, and in accordance with the following provisions: 

 

	 	(i)	 The Company shall, in its sole discretion, select the number of Advance Shares, not to exceed the Maximum
Advance Amount, it desires to issue and sell to the Investor in each Advance Notice and the time it desires to deliver each Advance Notice. 

  

	 	(ii)	 There shall be no mandatory minimum Advances and no non-usages fee for
not utilizing the Commitment Amount or any part thereof. 

  
 - 5 - 

	 	(b)	 Date of Delivery of Advance Notice. Advance Notices shall be delivered in accordance with the
instructions set forth on the bottom of Exhibit A. An Advance Notice shall be deemed delivered on (i) the day it is received by the Investor if such notice is received by email on or before 8:30 a.m. Eastern Time (or later if waived by
the Investor in its sole discretion), or (ii) the immediately succeeding day if it is received by email after 8:30 a.m. Eastern Time, in each case in accordance with the instructions set forth on the bottom of Exhibit A. 

 

	 	(c)	 Advance Limitations. Regardless of the number of Advance Shares requested by the Company in the Advance
Notice, the final number of Advance Shares to be issued and sold pursuant to an Advance Notice shall be reduced (if at all) in accordance with each of the following limitations: 

 

	 	(i)	 Ownership Limitation; Commitment Amount. Notwithstanding anything to the contrary contained in this
Agreement, the Investor shall not be obligated to purchase or acquire, and shall not purchase or acquire, any Common Shares under this Agreement which, when aggregated with all other Common Shares beneficially owned by the Investor and its
affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor and its affiliates (on an
aggregated basis) to exceed 9.99% of the outstanding voting power or number of then issued and outstanding Common Shares (the “Ownership Limitation”). Upon the written request of the Investor, the Company shall promptly (but no
later than the next business day on which the transfer agent for the Common Shares is open for business) confirm orally or in writing to the Investor the number of Common Shares then outstanding. In connection with each Advance Notice delivered by
the Company, any portion of the Advance that would (i) cause the Investor to exceed the Ownership Limitation or (ii) cause the aggregate number of Shares issued and sold to the Investor hereunder to exceed the Commitment Amount shall
automatically be withdrawn with no further action required by the Company, and such Advance Notice shall be deemed automatically modified to reduce the number of Advance Shares requested by an amount equal to such withdrawn portion; provided that in
the event of any such automatic withdrawal and automatic modification, Investor will promptly notify the Company of such event. 

  

	 	(ii)	 Registration Limitation and Exchange Cap. In no event shall an Advance exceed the amount registered
under the Registration Statement then in effect (the “Registration Limitation”) or the Exchange Cap, to the extent applicable. In connection with each Advance Notice, any portion of an Advance that would exceed the Registration
Limitation or the Exchange Cap shall automatically be withdrawn with no further action required by the Company and such Advance Notice shall be deemed automatically modified to reduce the aggregate amount of the requested Advance by an amount equal
to such withdrawn portion in respect of each Advance Notice; provided that in the event of any such automatic withdrawal and automatic modification, Investor will promptly notify the Company of such event. 

  
 - 6 - 

	 	(d)	 Minimum Acceptable Price. 

 

	 	(i)	 With respect to each Advance Notice, the Company may notify the Investor of the MAP with respect to such
Advance by indicating a MAP on such Advance Notice. If no MAP is specified in an Advance Notice, then no MAP shall be in effect in connection with such Advance. Each Trading Day during a Pricing Period for which (A) with respect to each Advance
Notice with a MAP, the VWAP of the Common Shares is below the MAP in effect with respect to such Advance Notice, or (B) there is no VWAP (each such day, an “Excluded Day”), shall result in an automatic reduction to the number
of Advance Shares set forth in such Advance Notice by one third (the resulting amount of each Advance being the “Adjusted Advance Amount”), and each Excluded Day shall be excluded from the Pricing Period for purposes of determining
the Market Price. 

  

	 	(ii)	 The total Advance Shares in respect of each Advance (after reductions have been made to arrive at the Adjusted
Advance Amount, if any) shall be automatically increased by such number of Common Shares (the “Additional Shares”) equal to the number of Common Shares sold by the Investor on such Excluded Day, if any, and the price paid per share
for each Additional Share shall be equal to the MAP in effect with respect to such Advance Notice (without any further discount), provided that this increase shall not cause the total Advance Shares to exceed the amount set forth in the original
Advance Notice or any limitations set forth in Section 2.01(c). 

  

	 	(e)	 Unconditional Contract. Notwithstanding any other provision in this Agreement, the Company and the
Investor acknowledge and agree that upon the Investor’s receipt of a valid Advance Notice from the Company, the parties shall be deemed to have entered into an unconditional contract binding on both parties for the purchase and sale of Advance
Shares pursuant to such Advance Notice in accordance with the terms of this Agreement and (i) subject to Applicable Laws and (ii) subject to Section 3.08 (Trading Activities), the Investor may sell Common Shares during the Pricing
Period. 

 Section 2.02 Closings. The closing of each Advance and each sale and purchase of Advance Shares (each, a
“Closing”) shall take place as soon as practicable on or after each Advance Date in accordance with the procedures set forth below. The parties acknowledge that the Purchase Price is not known at the time the Advance Notice is
delivered (at which time the Investor is irrevocably bound) but shall be determined on each Closing based on the daily prices of the Common Shares that are the inputs to the determination of the Purchase Price as set forth further below. In
connection with each Closing, the Company and the Investor shall fulfill each of its obligations as set forth below: 

  
 - 7 - 

	 	(a)	 On each Advance Date, the Investor shall deliver to the Company a written document, in the form attached hereto
as Exhibit B (each a “Settlement Document”), setting forth the final number of Shares to be purchased by the Investor (taking into account any adjustments pursuant to Section 2.01), the Market Price, the
Purchase Price, the aggregate proceeds to be paid by the Investor to the Company, and a report by Bloomberg, L.P. indicating the VWAP for each of the Trading Days during the Pricing Period (or, if not reported on Bloomberg, L.P., another reporting
service reasonably agreed to by the parties), in each case in accordance with the terms and conditions of this Agreement. 

  

	 	(b)	 Promptly after receipt of the Settlement Document with respect to each Advance (and, in any event, not later
than one Trading Day after such receipt), the Company will, or will cause its transfer agent to, electronically transfer such number of Advance Shares to be purchased by the Investor (as set forth in the Settlement Document) by crediting the
Investor’s account or its designee’s account at the Depository Trust Company through its Deposit Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto, and transmit
notification to the Investor that such share transfer has been requested. Promptly upon receipt of such notification, the Investor shall pay to the Company the aggregate purchase price of the Shares (as set forth in the Settlement Document) in cash
in immediately available funds to an account designated by the Company in writing and transmit notification to the Company that such funds transfer has been requested. No fractional shares shall be issued, and any fractional amounts shall be rounded
to the next higher whole number of shares. 

  

	 	(c)	 On or prior to the Advance Date, each of the Company and the Investor shall deliver to the other all documents,
instruments and writings expressly required to be delivered by either of them pursuant to this Agreement in order to implement and effect the transactions contemplated herein. 

 

	 	(d)	 Notwithstanding anything to the contrary in this Agreement, if on any day during the Pricing Period
(i) the Company notifies Investor that a Material Outside Event has occurred, or (ii) the Company notifies the Investor of a Black Out Period, the parties agree that the pending Advance shall end and the final number of Advance Shares to
be purchased by the Investor at the Closing for such Advance shall be equal to the number of Common Shares sold by the Investor during the applicable Pricing Period prior to the notification from the Company of a Material Outside Event or Black Out
Period. 

 Section 2.03 Hardship. 
  

	 	(a)	 In the event the Investor sells Common Shares after receipt of an Advance Notice and the Company fails to
perform its obligations as mandated in Section 2.02, the Company agrees that in addition to and in no way limiting the rights and obligations set forth in Article V hereto and in addition to any other remedy to which the Investor is entitled at
law or in equity, including, without limitation, specific performance, it will hold the Investor harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with
such default by the Company and acknowledges that irreparable damage may occur in the event of any such default. It is accordingly agreed that the Investor shall be entitled to an injunction or injunctions to prevent such breaches of this Agreement
and to specifically enforce (subject to Applicable Laws and the rules of the Principal Market), without the posting of a bond or other security, the terms and provisions of this Agreement. 

  
 - 8 - 

	 	(b)	 In the event the Company provides an Advance Notice and the Investor fails to perform its obligations as
mandated in Section 2.02, the Investor agrees that in addition to and in no way limiting the rights and obligations set forth in Article V hereto and in addition to any other remedy to which the Company is entitled at law or in equity,
including, without limitation, specific performance, it will hold the Company harmless against any loss, claim, damage, or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the
Investor and acknowledges that irreparable damage may occur in the event of any such default. It is accordingly agreed that the Company shall be entitled to an injunction or injunctions to prevent such breaches of this Agreement and to specifically
enforce (subject to Applicable Laws and the rules of the Principal Market), without the posting of a bond or other security, the terms and provisions of this Agreement. 

Section 2.04 Completion of Resale Pursuant to the Registration Statement. The Company will be under no further obligation to maintain the
effectiveness of the Registration Statement after the earlier to occur of (a) the date on which the Investor has purchased the full Commitment Amount and has completed the subsequent resale of the full Commitment Amount pursuant to the
Registration Statement, Investor will notify the Company that all subsequent resales are completed, (b) the 180th day following the date on which the Investor has purchased the full Commitment Amount, or (c) the 180th day following the
termination of this Agreement in accordance with its terms. 
 Article III. Representations and Warranties of Investor 

The Investor represents and warrants to the Company, as of the date hereof, as of each Advance Notice Date and each Advance Date that: 

Section 3.01 Organization and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman
Islands and has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to purchase or acquire Shares in accordance with the terms hereof. The decision to invest and the execution and delivery
of this Agreement by the Investor, the performance by the Investor of its obligations hereunder and the consummation by the Investor of the transactions contemplated hereby have been duly authorized and require no other proceedings on the part of
the Investor. The undersigned has the right, power and authority to execute and deliver this Agreement and all other instruments on behalf of the Investor or its shareholders. This Agreement has been duly executed and delivered by the Investor and,
assuming the execution and delivery hereof and acceptance thereof by the Company, will constitute the legal, valid and binding obligations of the Investor, enforceable against the Investor in accordance with its terms. 

  
 - 9 - 

 Section 3.02 Evaluation of Risks. The Investor has such knowledge and experience in financial,
tax and business matters as to be capable of evaluating the merits and risks of, and bearing the economic risks entailed by, an investment in the Common Shares of the Company and of protecting its interests in connection with the transactions
contemplated hereby. The Investor acknowledges and agrees that its investment in the Company involves a high degree of risk, and that the Investor may lose all or a part of its investment. 

Section 3.03 No Legal, Investment or Tax Advice from the Company. The Investor acknowledges that it had the opportunity to review this Agreement
and the transactions contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely on such counsel and advisors and not on any statements or representations of the Company or any of the
Company’s representatives or agents for legal, tax, investment or other advice with respect to the Investor’s acquisition of Common Shares hereunder, the transactions contemplated by this Agreement or the laws of any jurisdiction, and the
Investor acknowledges that the Investor may lose all or a part of its investment. 
 Section 3.04 Investment Purpose. The Investor is acquiring
the Common Shares for its own account, for investment purposes and not with a view towards, or for resale in connection with, the public sale or distribution thereof, in violation of the Securities Act or any applicable state securities
laws; provided, however, that by making the representations herein, the Investor does not agree, or make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves the right to dispose of
the Shares at any time in accordance with, or pursuant to, a Registration Statement filed pursuant to this Agreement or an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding, directly
or indirectly, with any Person to sell or distribute any of the Shares. The Investor is acquiring the Shares hereunder in the ordinary course of its business. The Investor acknowledges that it will be disclosed as an “underwriter” and a
“selling stockholder” in each Registration Statement and in any prospectus contained therein. 
 Section 3.05 Accredited Investor. The
Investor is an “Accredited Investor” as that term is defined in Rule 501(a)(3) of Regulation D. 
 Section 3.06 Information.
The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances and operations of the Company and information the Investor deemed material to making an informed investment decision.
The Investor and its advisors (and its counsel), if any, have been afforded the opportunity to ask questions of the Company and its management and have received answers to such questions. Neither such inquiries nor any other due diligence
investigations conducted by such Investor or its advisors (and its counsel), if any, or its representatives shall modify, amend or affect the Investor’s right to rely on the Company’s representations and warranties contained in this
Agreement. The Investor acknowledges and agrees that the Company has not made to the Investor, and the Investor acknowledges and agrees it has not relied upon, any representations and warranties of the Company, its employees or any third party other
than the representations and warranties of the Company contained in this Agreement. The Investor understands that its investment involves a high degree of risk. The Investor has sought such accounting, legal and tax advice, as it has considered
necessary to make an informed investment decision with respect to the transactions contemplated hereby. 

  
 - 10 - 

 Section 3.07 Not an Affiliate. The Investor is not an officer, director or a person that
directly, or indirectly through one or more intermediaries, controls or is controlled by, or is under common control with the Company or any “Affiliate” of the Company (as that term is defined in Rule 405 promulgated under the
Securities Act). 
 Section 3.08 No Prior Short Sales. At no time prior to the date of this Agreement has the Investor, its sole member, any of
their respective officers, or any entity managed or controlled by the Investor or its sole member, engaged in or effected, in any manner whatsoever, directly or indirectly, for its own principal account, any (i) “short sale” (as such term
is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Shares or (ii) hedging transaction, which establishes a net short position with respect to the Common Shares that remains in effect as of the date of this Agreement.

 Section 3.09 General Solicitation. Neither the Investor, nor any of its affiliates, nor any person acting on its or their behalf, has engaged
or will engage in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or sale of the Common Shares by the Investor. 

Section 3.10 Resale of Shares. The Investor represents, warrants and covenants that it will resell the Shares only pursuant to the Registration
Statement in which the resale of such Shares is registered under the Securities Act, in a manner described under the caption “Plan of Distribution” in such Registration Statement, and in a manner in compliance with all applicable federal
and state securities laws, rules and regulations, or pursuant to an exception for the registration provisions of the Securities Act, if applicable. 

Article IV. Representations and Warranties of the Company 

Except as set forth in the SEC Documents, the Company represents and warrants to the Investor, as of the date hereof, each Advance Notice Date
and each Advance Date (other than representations and warranties which address matters only as of a certain date, which shall be true and correct as written as of such certain date), that: 

Section 4.01 Organization and Qualification. Each of the Company and its Subsidiaries (as defined below) is an entity duly organized and validly
existing under the laws of their respective jurisdiction of organization, and has the requisite power and authority to own its properties and to carry on its business as now being conducted. Each of the Company and its Subsidiaries is duly qualified
to do business and is in good standing (to the extent applicable) in every jurisdiction in which the nature of the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good
standing would not have a Material Adverse Effect. 

  
 - 11 - 

 Section 4.02 Authorization, Enforcement, Compliance with Other Instruments. The Company has the
requisite corporate power and authority to enter into and perform its obligations under this Agreement and the other Transaction Documents and to issue the Shares in accordance with the terms hereof and thereof. The execution and delivery by the
Company of this Agreement and the other Transaction Documents, and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) have been or (with respect to
consummation) will be duly authorized by the Company’s board of directors and no further consent or authorization will be required by the Company, its board of directors or its shareholders. This Agreement and the other Transaction Documents to
which it is a party have been (or, when executed and delivered, will be) duly executed and delivered by the Company and, assuming the execution and delivery thereof and acceptance by the Investor, constitute (or, when duly executed and delivered,
will be) the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or other laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification and to contribution may be limited by
federal or state securities law. “Transaction Documents” means, collectively, this Agreement and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection with the transactions
contemplated hereby and thereby, as may be amended from time to time. 
 Section 4.03 Authorization of the Shares. The Shares to be issued under
this Agreement have been, or with respect to Shares to be purchased by the Investor pursuant to an Advance Notice, will be, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a duly authorized
committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, duly and validly authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security interest or
other claim, including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be registered pursuant to Section 12 of the Exchange Act. The Shares, when issued, will conform to
the description thereof set forth in or incorporated into the Prospectus. 
 Section 4.04 No Conflict. The execution, delivery and performance
of the Transaction Documents by the Company and the consummation by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) will not (i) result in a violation of the
articles of incorporation or other organizational documents of the Company or its Subsidiaries (with respect to consummation, as the same may be amended prior to the date on which any of the transactions contemplated hereby are consummated), (ii)
conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the Company or
its Subsidiaries or by which any property or asset of the Company or its Subsidiaries is bound or affected except, in the case of clause (ii) or (iii) above, to the extent such violations that would not reasonably be expected to have a Material
Adverse Effect. 

  
 - 12 - 

 Section 4.05 SEC Documents; Financial Statements. The Company has filed (giving effect to
permissible extensions in accordance with Rule 12b-25 under the Exchange Act) all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant to the Exchange Act
since June 16, 2021 (such filings, and amendments of such filings after the date hereof, or filed after the date hereof, and all exhibits included therein and financial statements and schedules thereto and documents incorporated by reference
therein, and all registration statements filed by the Company under the Securities Act (including any Registration statements filed hereunder), being hereinafter referred to as the “SEC Documents”). The Company has delivered or made
available to the Investor through the SEC’s website at http://www.sec.gov, true and complete copies of the SEC Documents. 
 Section 4.06
Financial Statements. The consolidated financial statements of the Company included or incorporated by reference in SEC Documents, together with the related notes and schedules, present fairly, in all material respects, the consolidated
financial position of the Company and the Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company for the periods specified and have been prepared in
compliance with the requirements of the Securities Act and Exchange Act and in conformity with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent basis (except for (i) such adjustments to
accounting standards and practices as are noted therein, (ii) in the case of unaudited interim financial statements, to the extent such financial statements may not include footnotes required by GAAP or may be condensed or summary statements
and (iii) such adjustments which will not be material, either individually or in the aggregate) during the periods involved; the other financial and statistical data with respect to the Company and the Subsidiaries (as defined below) contained
or incorporated by reference in the SEC Documents are accurately and fairly presented and prepared on a basis consistent with the financial statements and books and records of the Company; there are no financial statements (historical or pro forma)
that are required to be included or incorporated by reference in the SEC Documents that are not included or incorporated by reference as required; the Company and the Subsidiaries (as defined below) do not have any material liabilities or
obligations, direct or contingent (including any off-balance sheet obligations), not described in the SEC Documents (excluding the exhibits thereto); and all disclosures contained or incorporated by reference
in the SEC Documents regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission) comply in all material respects with Regulation G of the Exchange
Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the SEC Documents
fairly presents the information called for in all material respects and has been prepared in accordance with the SEC’s rules and guidelines applicable thereto. 

Section 4.07 Registration Statement and Prospectus. Each Registration Statement and the offer and sale of Shares as contemplated hereby will meet
the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule. Any statutes, regulations, contracts or other documents that are required to be described in a Registration Statement or a Prospectus, or
to be filed as exhibits to a Registration Statement have been so described or filed. Copies of each Registration Statement, any Prospectus, and any such amendments or supplements thereto and all documents incorporated by reference therein that were
filed with the Commission 

  
 - 13 - 

 
on or prior to the date of this Agreement have been delivered, or are available through EDGAR, to the Investor and its counsel. The Company has not distributed and, prior to the later to occur of
each Settlement Date and completion of the distribution of the Shares, will not distribute any offering material in connection with the offering or sale of the Shares other than a Registration Statement and the Prospectus and any Issuer Free Writing
Prospectus (as defined below) to which the Investor has consented, other than as required by Applicable Laws. 
 Section 4.08 No Misstatement or
Omission. Each Registration Statement, when it became or becomes effective, and any Prospectus, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the
Securities Act. At each Advance Date, the Registration Statement, and the Prospectus, as of such date, will conform in all material respects with the requirements of the Securities Act. Each Registration Statement, when it became or becomes
effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. Each Prospectus did not, or will not, include
an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference in a Prospectus or
any Prospectus Supplement did not, and any further documents filed and incorporated by reference therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated
in such document or necessary to make the statements in such document, in light of the circumstances under which they were made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance
upon, and in conformity with, information furnished to the Company by the Investor specifically for use in the preparation thereof. 
 Section 4.09
Conformity with Securities Act and Exchange Act. Each Registration Statement, each Prospectus, or any amendment or supplement thereto, and the documents incorporated by reference in each Registration Statement, Prospectus or any amendment or
supplement thereto, when such documents were or are filed with the SEC under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as the case may be, conformed or will conform in all material respects with
the requirements of the Securities Act and the Exchange Act, as applicable.
 Section 4.10 Equity Capitalization. As of the date hereof, the
authorized capital of the Company consists of 900,000,000 shares of capital stock, each with a par value of $0.0001, of which 600,000,000 shares are designated as Class A Common Stock, 200,000,000 shares are designated as Class B Common
Stock, and 100,000,000 shares are preferred stock (the “Preferred Stock”). As of June 30, 2022, the Company had 41,241,356 shares of Class A Common Stock outstanding, 121,561,877 shares of Class B Common Stock
outstanding, and no shares of Preferred Stock outstanding. 
 The Common Shares are registered pursuant to Section 12(b) of the
Exchange Act and is currently listed on a Principal Market under the trading symbol “GROV.” The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Shares under the Exchange
Act, delisting the Common Shares from the Principal Market, nor has the Company received any notification that the Commission or the Principal Market is contemplating terminating such registration or listing. To the Company’s knowledge, it is
in compliance with all applicable listing requirements of the Principal Market. 

  
 - 14 - 

 Section 4.11 Intellectual Property Rights. The Company and its Subsidiaries own or possess
adequate rights or licenses to use all material trademarks, trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and
rights, if any, necessary to conduct their respective businesses as now conducted, except as would not cause a Material Adverse Effect. The Company and its Subsidiaries have not received written notice of any infringement by the Company or its
Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, or trade secrets, except as would not cause a Material Adverse Effect. To the knowledge
of the Company, there is no claim, action or proceeding being made or brought against, or to the Company’s knowledge, being threatened against the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention,
copyright, license, service names, service marks, service mark registrations, trade secret or other infringement, except as would not cause a Material Adverse Effect. 

Section 4.12 Employee Relations. Neither the Company nor any of its Subsidiaries is involved in any labor dispute nor, to the knowledge of the
Company or any of its Subsidiaries, is any such dispute threatened, in each case which is reasonably likely to cause a Material Adverse Effect. 

Section 4.13 Environmental Laws. The Company and its Subsidiaries (i) have not received written notice alleging any failure to comply in all
material respects with all Environmental Laws (as defined below), (ii) have received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) have not
received written notice alleging any failure to comply with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and (iii), the failure to so comply would be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect. The term “Environmental Laws” means all applicable federal, state and local laws relating to pollution or protection of human health or the environment (including, without
limitation, ambient air, surface water, groundwater, land surface or subsurface strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder. 

Section 4.14 Title. Except as would not cause a Material Adverse Effect, the Company (or its Subsidiaries) have indefeasible fee simple or
leasehold title to its properties and material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance, claim or equitable interest other than such as are not material to the business of the Company. Any real property
and facilities held under lease by the Company and its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such
property and buildings by the Company and its Subsidiaries. 

  
 - 15 - 

 Section 4.15 Insurance. The Company and each of its Subsidiaries are insured by insurers of
recognized financial responsibility against such losses and risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries are engaged. The Company has no
reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a
Material Adverse Effect. 
 Section 4.16 Regulatory Permits. Except as would not cause a Material Adverse Effect, the Company and its
Subsidiaries possess all material certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to own their respective businesses, and neither the Company nor any such Subsidiary has
received any written notice of proceedings relating to the revocation or modification of any such certificate, authorization or permits. 

Section 4.17 Internal Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally
accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. 
 Section 4.18 Absence
of Litigation. Except as disclosed to the Investor, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending against or affecting the
Company, the Common Shares or any of the Company’s Subsidiaries, wherein an unfavorable decision, ruling or finding would have a Material Adverse Effect. 

Section 4.19 Subsidiaries. The Company does not, as of the date of this Agreement, have any Subsidiaries. 

Section 4.20 Tax Status. Except as would not have a Material Adverse Effect, each of the Company and its Subsidiaries (i) has timely made or
filed all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid all taxes and other governmental assessments and charges that are material
in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably adequate for the payment of all taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. The Company has not received written notification any unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company and its Subsidiaries know of no basis for any such claim where failure to pay would cause a Material Adverse Effect. 

  
 - 16 - 

 Section 4.21 Certain Transactions. Except as not required to be disclosed pursuant to Applicable
Laws, none of the officers or directors of the Company is presently a party to any transaction with the Company (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the
furnishing of services to or by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer or director, or to the knowledge of the Company, any corporation, partnership, trust or other
entity in which any officer or director has a substantial interest or is an officer, director, trustee or partner. 
 Section 4.22 Rights of First
Refusal. The Company is not obligated to offer the Common Shares offered hereunder on a right of first refusal basis or otherwise to any third parties including, but not limited to, current or former shareholders of the Company, underwriters,
brokers, agents or other third parties. 
 Section 4.23 Dilution. The Company is aware and acknowledges that issuance of Common Shares hereunder
could cause dilution to existing shareholders and could significantly increase the outstanding number of Common Shares. 
 Section 4.24
Acknowledgment Regarding Investor’s Purchase of Shares. The Company acknowledges and agrees that the Investor is acting solely in the capacity of an arm’s length investor with respect to this Agreement and the
transactions contemplated hereunder. The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated
hereunder and any advice given by the Investor or any of its representatives or agents in connection with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor’s purchase of the Shares hereunder. The
Company is aware and acknowledges that it shall not be able to request Advances under this Agreement if the Registration Statement is not effective or if any issuances of Common Shares pursuant to any Advances would violate any rules of the
Principal Market. 
 Section 4.25 Finder’s Fees. Neither the Company nor any of the Subsidiaries has incurred any liability for any
finder’s fees, brokerage commissions or similar payments in connection with the transactions herein contemplated.
 Section 4.26 Relationship
of the Parties. Neither the Company, nor any of its subsidiaries, affiliates, nor any person acting on its or their behalf is a client or customer of the Investor or any of its affiliates and neither the Investor nor any of its affiliates has
provided, or will provide, any services to the Company or any of its affiliates, its subsidiaries, or any person acting on its or their behalf. The Investor’s relationship to Company is solely as investor as provided for in the Transaction
Documents.
 Section 4.27 Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act
and Section 21E of the Exchange Act) contained in the Registration Statement or a Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. 

  
 - 17 - 

 Section 4.28 Compliance with Laws. The Company and each of its Subsidiaries are in material
compliance with Applicable Laws; to the knowledge of the Company, the Company has not received a notice of non-compliance that any director or officer, or employee of the Company or any Subsidiary nor, to the
Company’s knowledge, any agent, affiliate or other person acting on behalf of the Company or any Subsidiary has, has not complied with Applicable Laws, and is not aware of any pending change or contemplated change to any applicable law or
regulation or governmental position; in each case that would have a Material Adverse Effect. 
 Section 4.29 Sanctions Matters. Neither the
Company nor any of its Subsidiaries or, to the knowledge of the Company, any director, officer or controlled affiliate of the Company or any director or officer of any Subsidiary, is a Person that is, or is owned or controlled by a Person that is
(i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office of Foreign Asset Control (“OFAC”), the United Nations Security Council, the European Union, Her Majesty’s Treasury,
or other relevant sanctions authorities, including, without limitation, designation on OFAC’s Specially Designated Nationals and Blocked Persons List or OFAC’s Foreign Sanctions Evaders List or other relevant sanctions authority
(collectively, “Sanctions”), or (ii) located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including, without limitation, the
Crimea region, the Donetsk People’s Republic and Luhansk People’s Republic in Ukraine, Cuba, Iran, North Korea, Sudan and Syria (the “Sanctioned Countries”)). Neither the Company nor any of its Subsidiaries will, directly
or indirectly, use the proceeds from the sale of Advance Shares, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person (a) for the purpose of funding or facilitating any
activities or business of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or is a Sanctioned Country, or (b) in any other manner that will result in a violation of
Sanctions or Applicable Laws by any Person (including any Person participating in the transactions contemplated by this Agreement, whether as underwriter, advisor, investor or otherwise). For the past five years, neither the Company nor any of its
Subsidiaries has engaged in, and is now not engaged in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions or was a Sanctioned Country. 

Article V. Indemnification 

The Investor and the Company represent to the other the following with respect to itself: 

Section 5.01 Indemnification by the Company. In consideration of the Investor’s execution and delivery of this Agreement and acquiring the
Shares hereunder, and in addition to all of the Company’s other obligations under this Agreement, the Company shall defend, protect, indemnify and hold harmless the Investor and its investment manager, Yorkville Advisors Global, LP, and each of
their respective officers, directors, partners, employees and agents (including, without 

  
 - 18 - 

 
limitation, those retained in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act (collectively, the “Investor Indemnitees”) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and reasonable and
documented expenses in connection therewith (irrespective of whether any such Investor Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable attorneys’ fees and disbursements (the
“Indemnified Liabilities”), incurred by the Investor Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that the Company will not be liable in any such case to the extent that any such
loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company
by or on behalf of the Investor specifically for inclusion therein; (b) any material misrepresentation or breach of any material representation or material warranty made by the Company in this Agreement or any other certificate, instrument or
document contemplated hereby or thereby; or (c) any material breach of any material covenant, material agreement or material obligation of the Company contained in this Agreement or any other certificate, instrument or document contemplated
hereby or thereby. To the extent that the foregoing undertaking by the Company may be unenforceable under Applicable Law, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which
is permissible under Applicable Law. 
 Section 5.02 Indemnification by the Investor. In consideration of the Company’s execution and
delivery of this Agreement, and in addition to all of the Investor’s other obligations under this Agreement, the Investor shall defend, protect, indemnify and hold harmless the Company and all of its officers, directors, shareholders, employees
and agents (including, without limitation, those retained in connection with the transactions contemplated by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act (collectively, the “Company Indemnitees”) from and against any and all Indemnified Liabilities incurred by the Company Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue
statement or alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any amendment thereof or
supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that
the Investor will only be liable for written information relating to the Investor furnished to the Company by or on behalf of the Investor specifically for inclusion in the documents referred to in the foregoing indemnity, and will not be liable in
any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with
written information furnished to the Investor by or on behalf of the 

  
 - 19 - 

 
Company specifically for inclusion therein; (b) any misrepresentation or breach of any representation or warranty made by the Investor in this Agreement or any instrument or document
contemplated hereby or thereby executed by the Investor; or (c) any breach of any covenant, agreement or obligation of the Investor contained in this Agreement or any other certificate, instrument or document contemplated hereby or thereby
executed by the Investor. To the extent that the foregoing undertaking by the Investor may be unenforceable under Applicable Laws, the Investor shall make the maximum contribution to the payment and satisfaction of each of the Indemnified
Liabilities, which is permissible under Applicable Laws. 
 Section 5.03 Notice of Claim. Promptly after receipt by an Investor Indemnitee or
Company Indemnitee of notice of the commencement of any action or proceeding (including any governmental action or proceeding) involving an Indemnified Liability, such Investor Indemnitee or Company Indemnitee, as applicable, shall, if a claim for
an Indemnified Liability in respect thereof is to be made against any indemnifying party under this Article V, deliver to the indemnifying party a written notice of the commencement thereof; but the failure to so notify the indemnifying party will
not relieve it of liability under this Article V except to the extent the indemnifying party is prejudiced by such failure. The indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly
with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually reasonably satisfactory to the indemnifying party and the Investor Indemnitee or Company Indemnitee, as the case may be; provided,
however, that an Investor Indemnitee or Company Indemnitee shall have the right to retain its own counsel with the actual and reasonable third party fees and expenses of not more than one counsel for such Investor Indemnitee or Company Indemnitee to
be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of the Investor Indemnitee or Company Indemnitee and the indemnifying party would be inappropriate due
to actual or potential differing interests between such Investor Indemnitee or Company Indemnitee and any other party represented by such counsel in such proceeding. The Investor Indemnitee or Company Indemnitee shall cooperate fully with the
indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Investor Indemnitee or Company Indemnitee
which relates to such action or claim. The indemnifying party shall keep the Investor Indemnitee or Company Indemnitee reasonably apprised as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party
shall be liable for any settlement of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party
shall, without the prior written consent of the Investor Indemnitee or Company Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the giving by the
claimant or plaintiff to such Investor Indemnitee or Company Indemnitee of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated to all
rights of the Investor Indemnitee or Company Indemnitee with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The indemnification required by this Article V shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received and payment therefor is due. 

  
 - 20 - 

 Section 5.04 Remedies. The remedies provided for in this Article V are not exclusive and shall
not limit any right or remedy which may be available to any indemnified person at law or equity. The obligations of the parties to indemnify or make contribution under this Article V shall survive expiration or termination of this Agreement. 

Section 5.05 Limitation of liability. Notwithstanding the foregoing, no party shall be entitled to recover from the other party for punitive,
indirect, incidental or consequential damages. 
 Article VI. 

Covenants 
 The Company covenants with the
Investor, and the Investor covenants with the Company, as follows, which covenants of one party are for the benefit of the other party, during the Commitment Period: 

Section 6.01 Registration Statement. 
  

	 	(a)	 Filing of a Registration Statement. The Company shall prepare and file with the SEC a Registration
Statement, or multiple Registration Statements for the resale by the Investor of the Registrable Securities. The Company in its sole discretion may choose when to file such Registration Statements; provided, however, that the Company shall
not have the ability to request any Advances until the effectiveness of a Registration Statement. 

  

	 	(b)	 Maintaining a Registration Statement. The Company shall use commercially reasonable efforts to maintain
the effectiveness of any Registration Statement with respect to the Shares that has been declared effective at all times during the Commitment Period, provided, however, that if the Company has received notification pursuant to Section 2.04
that the Investor has completed resales pursuant to the Registration Statement for the full Commitment Amount, then the Company shall be under no further obligation to maintain the effectiveness of the Registration Statement. Notwithstanding
anything to the contrary contained in this Agreement, the Company shall ensure that, when filed, each Registration Statement (including, without limitation, all amendments and supplements thereto) and the prospectus (including, without limitation,
all amendments and supplements thereto) used in connection with such Registration Statement shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements
therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading. During the Commitment Period, the Company shall notify the Investor promptly if (i) the Registration Statement shall cease to be
effective under the Securities Act, (ii) the Common Shares shall cease to be authorized for listing on the Principal Market, (iii) the Common Shares cease to be registered under Section 12(b) or Section 12(g) of the Exchange Act
or (iv) the Company fails to file in a timely manner all reports and other documents required of it as a reporting company under the Exchange Act. 

  
 - 21 - 

	 	(c)	 Filing Procedures. The Company shall (A) permit counsel to the Investor an opportunity to review
and comment upon (i) each Registration Statement prior to its filing with the SEC and (ii) all amendments and supplements to each Registration Statement (including, without limitation, the Prospectus contained therein) (except for Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any similar or successor reports or
Prospectus Supplements the contents of which is limited to that set forth in such reports) within a reasonable number of days prior to their filing with the SEC, and (B) shall reasonably consider any comments of the Investor and its counsel on
any such Registration Statement or amendment or supplement thereto or to any Prospectus contained therein. The Company shall promptly furnish to the Investor, without charge, (i) electronic copies of any correspondence from the SEC or the Staff
to the Company or its representatives relating to each Registration Statement (which correspondence shall be redacted to exclude any material, non-public information regarding the Company or any of
its Subsidiaries), (ii) after the same is prepared and filed with the SEC, one (1) electronic copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules,
all documents incorporated therein by reference, if requested by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) electronic copy of the Prospectus included in such Registration
Statement and all amendments and supplements thereto; provided, however, the Company shall not be required to furnish any document to the extent such document is available on EDGAR). 

 

	 	(d)	 Amendments and Other Filings. The Company shall (i) prepare and file with the SEC such amendments
(including post-effective amendments) and supplements to a Registration Statement and the related prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities
Act, as may be necessary to keep such Registration Statement effective at all times during the Commitment Period, and prepare and file with the SEC such additional Registration Statements in order to register for resale under the Securities Act all
of the Registrable Securities; (ii) during the Commitment Period, cause the related prospectus to be amended or supplemented by any required prospectus supplement (subject to the terms of this Agreement), and as so supplemented or amended to be
filed pursuant to Rule 424 promulgated under the Securities Act; (iii) during the Commitment Period, provide the Investor copies of all correspondence from and to the SEC relating to a Registration Statement (provided that the Company may
excise any information contained therein which would constitute material non-public information), and (iv) during the Commitment Period, comply with the provisions of the Securities Act with respect to
the disposition of all Common Shares of the Company covered by such Registration Statement until such time as all of such Common Shares shall have been disposed of in accordance with the intended methods of disposition by the seller or sellers
thereof as set forth in such Registration Statement. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant to this Section 6.01(d) by reason of the
Company’s filing a report on Form 10-K, Form 10-Q, or Form 8-K or any analogous report under the Exchange Act, the Company
shall 

  
 - 22 - 

	 	
file such report in a prospectus supplement filed pursuant to Rule 424 promulgated under the Securities Act to incorporate such filing into the Registration Statement, if applicable, or shall
file such amendments or supplements with the SEC either on the day on which the Exchange Act report is filed which created the requirement for the Company to amend or supplement the Registration Statement, if feasible, or shall otherwise use its
commercially reasonable efforts to file it promptly thereafter. 

  

	 	(e)	 Blue-Sky. The Company shall use its commercially
reasonable efforts to, if required by Applicable Laws, (i) register and qualify the Common Shares covered by a Registration Statement under such other securities or “blue sky” laws of such jurisdictions in the United States as the
Investor reasonably requests, (ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness thereof
during the Commitment Period, (iii) take such other actions as may be necessary to maintain such registrations and qualifications in effect at all times during the Commitment Period, and (iv) take all other actions reasonably necessary or
advisable to qualify the Common Shares for sale in such jurisdictions; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (w) make any change to its Articles of Incorporation or Bylaws
or any other organizational documents of the Company or any of its Subsidiaries, (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 6.01, (y) subject itself to general
taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify the Investor of the receipt by the Company of any notification with respect to the suspension of
the registration or qualification of any of the Common Shares for sale under the securities or “blue sky” laws of any jurisdiction in the United States or its receipt of actual notice of the initiation or threat of any proceeding for such
purpose. 

 Section 6.02 Suspension of Registration Statement. 

 

	 	(a)	 Establishment of a Black Out Period. During the Commitment Period, the Company from time to time may
suspend the use of the Registration Statement by written notice to the Investor in the event that the Company determines in its sole discretion in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic
information concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company or (B) amend or supplement the Registration Statement or Prospectus so that such
Registration Statement or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading (a “Black Out Period”). 

  

	 	(b)	 No Sales by Investor During the Black Out Period. During such Black Out Period, the Investor agrees not
to sell any Common Shares of the Company. 

  
 - 23 - 

	 	(c)	 Limitations on the Black Out Period. The Company shall not impose any Black Out Period that is longer
than 45 days or in a manner that is more restrictive (including, without limitation, as to duration) than the comparable restrictions that the Company may impose on transfers of the Company’s equity securities by its directors and senior
executive officers. In addition, the Company shall not deliver any Advance Notice during any Black Out Period. If the public announcement of such material, nonpublic information is made during a Black Out Period, the Black Out Period shall terminate
immediately after such announcement, and the Company shall immediately notify the Investor of the termination of the Black Out Period. 

Section 6.03 Listing of Common Shares. As of each Advance Date, the Shares to be sold by the Company from time to time hereunder will have been
registered under Section 12(b) of the Exchange Act and approved for listing on the Principal Market, subject to official notice of issuance. 

Section 6.04 Opinion of Counsel. Prior to the date of the delivery by the Company of the first Advance Notice, the Investor shall have received an
opinion letter from counsel to the Company in form and substance reasonably satisfactory to the Investor. 
 Section 6.05 Exchange Act
Registration. The Company will file in a timely manner all reports and other documents required of it as a reporting company under the Exchange Act and will not take any action or file any document (whether or not permitted by Exchange Act or
the rules thereunder) to terminate or suspend its reporting and filing obligations under the Exchange Act. 
 Section 6.06 Transfer Agent
Instructions. For any time while there is a Registration Statement in effect for this transaction, the Company shall (if required by the transfer agent for the Common Shares) cause legal counsel for the Company to deliver to the transfer agent
for the Common Shares (with a copy to the Investor) instructions to issue Common Shares to the Investor free of restrictive legends upon each Advance if the delivery of such instructions are consistent with Applicable Law; provided that legal
counsel for the Company shall have been furnished with such documents as they may require for the purposes of enabling them to render the opinions or make the statements requested by the transfer agent, or in order to evidence the accuracy of any of
the representations or warranties, or the fulfillment of any of the covenants, obligations or conditions, contained herein. 
 Section 6.07
Corporate Existence. The Company will use commercially reasonable efforts to preserve and continue the corporate existence of the Company during the Commitment Period. 

Section 6.08 Notice of Certain Events Affecting Registration; Suspension of Right to Make an Advance. During the Commitment Period, the Company
will promptly notify the Investor, and confirm in writing, upon its becoming aware of the occurrence of any of the following events in respect of a Registration Statement or related Prospectus (in each of which cases the information provided to
Investor will be kept strictly confidential): (i) except for requests made in connection with SEC investigations disclosed in the SEC Documents, receipt of any request for additional information by the SEC or any other Federal or state governmental
authority during the period of effectiveness of the Registration Statement or any request for amendments or supplements to the Registration Statement or related Prospectus; (ii) the issuance by the SEC or any other Federal governmental
authority of any stop order suspending the effectiveness of the Registration 

  
 - 24 - 

 
Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect to the suspension of the qualification or exemption from qualification of any
of the Common Shares for sale in any jurisdiction or the initiation or written threat of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in the Registration Statement or related Prospectus or any
document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, related Prospectus or documents so that, in the case of the Registration
Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and that in the case of the related Prospectus, it
will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or
of the necessity to amend the Registration Statement or supplement a related Prospectus to comply with the Securities Act or any other law; (v) the Company’s reasonable determination that a post-effective amendment to the Registration
Statement would be required and the Company will promptly make available to the Investor any such supplement or amendment to the related Prospectus; (vi) the Common Shares shall cease to be authorized for listing on the Principal Market; or
(vii) the Company fails to file in a timely manner all reports and other documents required of it as a reporting company under the Exchange Act. The Company shall not deliver to the Investor any Advance Notice, and the Company shall not sell
any Shares pursuant to any pending Advance Notice (other than as required pursuant to Section 2.02(d)), during the continuation of any of the foregoing events (each of the events described in the immediately preceding clauses (i) through
(vii), inclusive, a “Material Outside Event”). 
 Section 6.09 Consolidation. If an Advance Notice has been delivered to the
Investor, then the Company shall not effect any consolidation of the Company with or into, or a transfer of all or substantially all the assets of the Company to another entity before the transaction contemplated in such Advance Notice has been
closed in accordance with Section 2.02 hereof, and all Shares in connection with such Advance have been received by the Investor. 
 Section 6.10
Issuance of the Company’s Common Shares. The issuance and sale of the Common Shares hereunder shall be made in accordance with the provisions and requirements of Section 4(a)(2) of the Securities Act and any applicable state
securities law. 
 Section 6.11 Expenses. The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement
is terminated, will pay all expenses incident to the performance of its obligations hereunder, including but not limited to (i) the preparation, printing and filing of the Registration Statement and each amendment and supplement thereto, of
each prospectus and of each amendment and supplement thereto; (ii) the preparation, issuance and delivery of any Shares issued pursuant to this Agreement, (iii) all fees and disbursements of the Company’s counsel, accountants and
other advisors (but not, for the avoidance doubt, the fees and disbursements of Investor’s counsel, accountants and other advisors), (iv) the qualification of the Shares under securities laws in accordance with the provisions of this Agreement,
including filing fees in connection therewith, (v) the printing and delivery of copies of any prospectus and any amendments or supplements thereto, (vi) the fees and expenses incurred in connection with the listing or qualification of the
Shares for trading on the Principal Market, or (vii) filing fees of the SEC and the Principal Market. 

  
 - 25 - 

 Section 6.12 Current Report. The Company shall, not later than 5:30 p.m., New York City time, on
the fourth business day after the date of this Agreement, file with the SEC a Current Report on Form 8-K disclosing the execution of this Agreement by the Company and the Investor (including any
exhibits thereto, the “Current Report”). The Company shall provide the Investor and its legal counsel a reasonable opportunity to comment on a draft of the Current Report prior to filing the Current Report with the SEC and shall
give due consideration to all such comments. From and after the filing of the Current Report with the SEC, the Company shall have publicly disclosed all material, nonpublic information delivered to the Investor (or the Investor’s
representatives or agents) by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, agents or representatives (if any) in connection with the transactions contemplated by the Transaction
Documents. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers, directors, employees and agents not to, provide the Investor with any material,
non-public information regarding the Company or any of its Subsidiaries without the express prior written consent of the Investor (which may be granted or withheld in the Investor’s sole discretion); it
being understood that the mere notification of Investor required pursuant to Section 6.08(iv) hereof shall not in and of itself be deemed to be material non-public information. Notwithstanding anything
contained in this Agreement to the contrary, the Company expressly agrees that it shall publicly disclose in the Current Report any information communicated to the Investor by or, to the knowledge of the Company, on behalf of the Company in
connection with the transactions contemplated herein, which, following the date hereof would, if not so disclosed, constitute material, non-public information regarding the Company or its Subsidiaries. The
Company understands and confirms that the Investor will reply on the foregoing representations in effecting resales of Shares under the Registration Statement. 

Section 6.13 Advance Notice Limitation. The Company shall not deliver an Advance Notice if a shareholder meeting or corporate action date, or the
record date for any shareholder meeting or any corporate action, would fall during the period beginning two Trading Days prior to the date of delivery of such Advance Notice and ending two Trading Days following the Closing of such Advance. 

Section 6.14 Use of Proceeds. The proceeds from the sale of the Shares by the Company to Investor shall be used by the Company in the manner as
will be set forth in the Prospectus included in any Registration Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto filed pursuant to this Agreement. 

Section 6.15 Compliance with Laws. The Company shall comply in all material respects with all Applicable Laws. 

Section 6.16 Market Activities. Neither the Company, nor any Subsidiary, nor any of their respective officers, directors or controlling persons
will, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute or result, in the stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of Common Shares or (ii) sell, bid for, or purchase Common Shares in violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Shares. 

  
 - 26 - 

 Section 6.17 Trading Information. Upon the Company’s request, the Investor agrees to
provide the Company with trading reports setting forth the number and average sales prices of shares of Common Shares sold by the Investor during the prior trading week. 

Section 6.18 Selling Restrictions. (i) Except as expressly set forth below, the Investor covenants that from and after the date hereof
through and including the Trading Day next following the expiration or termination of this Agreement as provided in Section 11.01 (the “Restricted Period”), none of the Investor any of its officers, or any entity managed or
controlled by the Investor (collectively, the “Restricted Persons” and each of the foregoing is referred to herein as a “Restricted Person”) shall, directly or indirectly, engage in any “short sale” (as
such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Shares or (ii) hedging transaction, which establishes a net short position with respect to any securities of the Company (including the Common Shares), with
respect to each of clauses (i) and (ii) hereof, either for its own principal account or for the principal account of any other Restricted Person. Notwithstanding the foregoing, it is expressly understood and agreed that nothing contained herein
shall (without implication that the contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period from: (1) selling “long” (as defined under Rule 200 promulgated under Regulation SHO) the Shares; or
(2) selling a number of Common Shares equal to the number of Advance Shares that such Restricted Person is unconditionally obligated to purchase under a pending Advance Notice but has not yet received from the Company or the transfer agent
pursuant to this Agreement. 
 Section 6.19 Assignment. Neither this Agreement nor any rights or obligations of the parties hereto may be
assigned to any other Person. 
 Section 6.20 Non-Public Information. The Company covenants and agrees
that, other than as expressly required by Section 6.08 hereof, or, with the Investor’s consent pursuant to Section 6.13, it shall refrain from disclosing, and shall cause its officers, directors, employees and agents to refrain from
disclosing, any material non-public information (as determined under the Securities Act, the Exchange Act, or the rules and regulations of the SEC) to the Investor without also disseminating such information
to the public, unless prior to disclosure of such information the Company identifies such information as being material non-public information and provides the Investor with the opportunity to accept or refuse
to accept such material non-public information for review. Unless specifically agreed to in writing, in no event shall the Investor have a duty of confidentiality or be deemed to have agreed to maintain
information in confidence, with respect to the delivery of any Advance Notices. 

  
 - 27 - 

 Article VII. 

Conditions for Delivery of Advance Notice 

Section 7.01 Conditions Precedent to the Right of the Company to Deliver an Advance Notice. The right of the Company to deliver an Advance Notice
and the obligations of the Investor hereunder with respect to an Advance are subject to the satisfaction or waiver, on each Advance Notice Date (a “Condition Satisfaction Date”), of each of the following conditions: 

 

	 	(a)	 Accuracy of the Company’s Representations and Warranties. The representations and
warranties of the Company in this Agreement shall be true and correct in all material respects. 

  

	 	(b)	 Registration of the Common Shares with the SEC. There is an effective Registration Statement pursuant to
which the Investor is permitted to utilize the prospectus thereunder to resell all of the Common Shares issuable pursuant to such Advance Notice. 

  

	 	(c)	 Authority. The Company shall have obtained all permits and qualifications required by any applicable
state for the offer and sale of all the Common Shares issuable pursuant to such Advance Notice, or shall have the availability of exemptions therefrom. The sale and issuance of such Common Shares shall be legally permitted by all laws and
regulations to which the Company is subject. 

  

	 	(d)	 No Material Outside Event. No Material Outside Event shall have occurred and be continuing.

  

	 	(e)	 Performance by the Company. The Company shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior the applicable Condition Satisfaction Date. 

 

	 	(f)	 No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have
been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits or directly, materially and adversely affects any of the transactions contemplated by this Agreement.

  

	 	(g)	 No Suspension of Trading in or Delisting of Common Shares. The Common Shares are quoted for trading on
the Principal Market and all of the Shares issuable pursuant to such Advance Notice will be listed or quoted for trading on the Principal Market. The issuance of Common Shares with respect to the applicable Advance Notice will not violate the
shareholder approval requirements of the Principal Market. The Company shall not have received any written notice that is then still pending threatening the continued quotation of the Common Shares on the Principal Market. 

 

	 	(h)	 Authorized. There shall be a sufficient number of authorized but unissued and otherwise unreserved
Common Shares for the issuance of all of the Shares issuable pursuant to such Advance Notice. 

  

	 	(i)	 Executed Advance Notice. The representations contained in the applicable Advance Notice shall be true
and correct in all material respects as of the applicable Condition Satisfaction Date. 

  
 - 28 - 

	 	(j)	 Consecutive Advance Notices. Except with respect to the first Advance Notice, the Company shall have
delivered all Shares relating to all prior Advances. 

 Article VIII. 

Non Exclusive Agreement 

Notwithstanding anything contained herein, this Agreement and the rights awarded to the Investor hereunder are
non-exclusive, and the Company may, at any time throughout the term of this Agreement and thereafter, issue and allot, or undertake to issue and allot, any shares and/or securities and/or convertible notes,
bonds, debentures, options to acquire shares or other securities and/or other facilities which may be converted into or replaced by Common Shares or other securities of the Company, and to extend, renew and/or recycle any bonds and/or debentures,
and/or grant any rights with respect to its existing and/or future share capital. 
 Article IX. 

Choice of Law/Jurisdiction 

This Agreement shall be governed by and interpreted in accordance with the laws of the State of New York without regard to the principles of
conflict of laws. The parties further agree that any action between them shall be heard in New York County, New York, and expressly consent to the jurisdiction and venue of the Supreme Court of New York, sitting in New York County, New York and the
United States District Court of the Southern District of New York, sitting in New York, New York, for the adjudication of any civil action asserted pursuant to this Agreement. 

Article X. Termination 

Section 10.01 Termination. 
  

	 	(a)	 Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest
of (i) the first day of the month next following the 36-month anniversary of the date hereof or (ii) the date on which the Investor shall have made payment of Advances pursuant to this Agreement for
Common Shares equal to the Commitment Amount. 

  

	 	(b)	 The Company may terminate this Agreement effective upon five Trading Days’ prior written notice to the
Investor; provided that (i) there are no outstanding Advance Notices, the Common Shares under which have yet to be issued, and (ii) the Company has paid all amounts owed to the Investor pursuant to this Agreement. This Agreement may be
terminated at any time by the mutual written consent of the parties, effective as of the date of such mutual written consent unless otherwise provided in such written consent. 

 

	 	(c)	 Nothing in this Section 10.01 shall be deemed to release the Company or the Investor from any liability
for any breach under this Agreement, or to impair the rights of the Company and the Investor to compel specific performance by the other party of its obligations under this Agreement. The indemnification provisions contained in Article V shall
survive termination hereunder. 

  
 - 29 - 

 Article XI. Notices 

Other than with respect to Advance Notices, which must be in writing and will be deemed delivered on the day set forth in
Section 2.01(b), any notices, consents, waivers, or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed to have been delivered (i) upon receipt, when delivered
personally; (ii) upon receipt, when sent by facsimile or e-mail if sent on a Trading Day, or, if not sent on a Trading Day, on the immediately following Trading Day; (iii) 5 days after being sent by U.S.
certified mail, return receipt requested, (iv) 1 day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications
(except for Advance Notices which shall be delivered in accordance with Exhibit A hereof) shall be: 
  

			
	If to the Company, to:	  	 Grove Collaborative Holdings, Inc.
 1301 Sansome
Street
 San Francisco, CA 94111

		  	Attention: Stuart Landesberg
		  	Email: [*****]
		
	 With a copy to (which shall not

constitute notice or delivery of process) to:
	  	
		  	 Grove Collaborative Holdings, Inc.
 1301 Sansome
Street
 San Francisco, CA 94111
 Attention: Delida Costin

Email: [*****]

		
		  	 and
  

Sidley Austin LLP
 1001 Page Mill Road, Building 1

Palo Alto, CA 94304
 Attention: Martin A. Wellington

Email: [*****]

		
	If to the Investor(s):	  	YA II PN, Ltd.
		  	1012 Springfield Avenue
		  	Mountainside, NJ 07092
		  	Attention: Mark Angelo
		  	  Portfolio Manager

			
		  	Telephone: [*****]
		  	Email:[*****] 

  
 - 30 - 

			
	 With a Copy (which shall not
 constitute notice
or delivery of process) to:
	  	 David Fine, Esq.
 1012 Springfield Avenue

Mountainside, NJ 07092

		  	Telephone: [*****]
		  	Email: [*****]

 or at such other address and/or e-mail and/or to the attention of such other person as
the recipient party has specified by written notice given to each other party three Business Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice, consent, waiver or other
communication, (ii) electronically generated by the sender’s email service provider containing the time, date, recipient email address or (iii) provided by a nationally recognized overnight delivery service shall be rebuttable
evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively. 

Article XII. Miscellaneous 

Section 12.01 Counterparts. This Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned and delivered signatures (including any electronic signature covered by the U.S. federal ESIGN
Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), including by e-mail attachment, shall be deemed to have been
duly and validly delivered and be valid and effective for all purposes of this Agreement. 
 Section 12.02 Entire Agreement; Amendments. This
Agreement supersedes all other prior oral or written agreements between the Investor, the Company, their respective affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement contains the entire
understanding of the parties with respect to the matters covered herein and, except as specifically set forth herein, neither the Company nor the Investor makes any representation, warranty, covenant or undertaking with respect to such matters. No
provision of this Agreement may be waived or amended other than by an instrument in writing signed by the parties to this Agreement. 
 Section 12.03
Reporting Entity for the Common Shares. The reporting entity relied upon for the determination of the trading price or trading volume of the Common Shares on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or
any successor thereto. The written mutual consent of the Investor and the Company shall be required to employ any other reporting entity. 

  
 - 31 - 

 Section 12.04 Commitment and Structuring Fee. Each of the parties shall pay its own fees and
expenses (including the fees of any attorneys, accountants, appraisers or others engaged by such party) in connection with this Agreement and the transactions contemplated hereby, except that the Company has paid to YA Global II SPV, LLC, a
subsidiary of the Investor, a structuring fee in the amount of $10,000, which the Investor acknowledges has been received prior to the date hereof. 

Section 12.05 Brokerage. Each of the parties hereto represents that it has had no dealings in connection with this transaction with any finder or
broker who will demand payment of any fee or commission from the other party. The Company on the one hand, and the Investor, on the other hand, agree to indemnify the other against and hold the other harmless from any and all liabilities to any
person claiming brokerage commissions or finder’s fees on account of services purported to have been rendered on behalf of the indemnifying party in connection with this Agreement or the transactions contemplated hereby. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 - 32 - 

 IN WITNESS WHEREOF, the parties hereto have caused this STANDBY EQUITY PURCHASE
AGREEMENT to be executed by the undersigned, thereunto duly authorized, as of the date first set forth above. 
  

					
	COMPANY:
	GROVE COLLABORATIVE HOLDINGS, INC.
		
	By:	 	 /s/ Stuart Landesberg

	Name: Stuart Landesberg
	Title: CEO
	
	INVESTOR:
	YA II PN, LTD.
		
	By:	 	Yorkville Advisors Global, LP
	Its:	 	Investment Manager
			
		 	By:	 	Yorkville Advisors Global II, LLC
		 	Its:	 	General Partner
			
		 	By:	 	 /s/ Matt Beckman

		 	Name:	 	Matt Beckman
		 	Title: Member

  
 - 33 - 

 EXHIBIT A 

FORM OF ADVANCE NOTICE 
 VIA EMAIL

 GROVE COLLABORATIVE HOLDINGS, INC. 

Dated:
______________                                       
                                         
                                     Advance Notice Number: ____

 The undersigned, _______________________, hereby certifies, with respect to the sale of shares of Class A Common Stock, par
value $0.0001 per share, of GROVE COLLABORATIVE HOLDINGS, INC. (the “Company”) issuable in connection with this Advance Notice, delivered pursuant to that certain STANDBY EQUITY PURCHASE AGREEMENT, dated as of July 18, 2022
(the “Agreement”), as follows (with capitalized terms used herein without definition having the same meanings as given to them in the Agreement): 

1. The undersigned is the duly elected ______________ of the Company. 

2. There are no fundamental changes to the information set forth in the Registration Statement which would require the Company to file a
post-effective amendment to the Registration Statement. 
 3. The Company has performed in all material respects all covenants and agreements
to be performed by the Company contained in this Agreement on or prior to the Advance Notice Date. All conditions to the delivery of this Advance Notice are satisfied as of the date hereof. 

4. The number of Advance Shares the Company is requesting is _____________________. 

5. The Minimum Acceptable Price with respect to this Advance Notice is _________ (if left blank then no Minimum Acceptable Price will be
applicable to this Advance). 
 6. The number of shares of Class A Common Stock of the Company outstanding as of the date hereof is
___________. 
 The undersigned has executed this Advance Notice as of the date first set forth above. 

 

			
	GROVE COLLABORATIVE HOLDINGS, INC.
		
	By:	 	              

	Name:	 	
	Title:	 	

 Please deliver this Advance Notice by email to: 

Email: [*****] 
 Attention:
Trading Department and Compliance Officer 
 Confirmation Telephone Number: [*****] 

 EXHIBIT B 

FORM OF SETTLEMENT DOCUMENT 
 VIA
EMAIL 
 GROVE COLLABORATIVE HOLDINGS, INC. (the “Company”) 

Attn:      
 Email: 

 

			
		  	Below please find the settlement information with respect to the Advance Notice Date of:
		
	1.	  	Advance requested in the Advance Notice
		
	2.	  	Minimum Acceptable Price for this Advance (if any)
		
	3.	  	Number of Excluded Days (if any)
		
	4.	  	Adjusted Advance Amount (after taking into account any adjustments pursuant to Section 2.01):
		
	5.	  	Market Price
		
	6.	  	Purchase Price (Market Price x 97.55%) per share
		
	7.	  	Number of Advance Shares due to Investor
	
	If there were any Excluded Days then add the following (see Section 2.01(d)): 
		
	8.	  	Number of Additional Shares to be issued to Investor
		
	9.	  	Additional amount to be paid to the Company by the Investor (Additional Shares in number 8 x Minimum Acceptable Price)
		
	10.	  	Total Amount to be paid to Company (Purchase Price in number 6 + Additional amount in number 9):
		
	11.	  	Total Shares to be issued to Investor (Shares due to Investor in number 7 + Additional Shares in number 8):

 Please issue the number of Advance Shares due to the Investor to the account of the Investor as follows: 

INVESTOR’S DTC PARTICIPANT #: 
 ACCOUNT
NAME:  
 ACCOUNT NUMBER: 
 ADDRESS:

 CITY: 

COUNTRY:                 

CONTACT PERSON: 
 NUMBER AND/OR EMAIL: 

 
	
	Sincerely,
	
	YA II PN, LTD.
	
	              

	Name:
	Title:

  

	
	Agreed and Approved:
	
	GROVE COLLABORATIVE HOLDINGS, INC.:
	
	              

	Name:
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00346-of-00352.parquet"}]]